News
-
Triple pill for high BP
Thursday | Aug 16 2018A NEW approach to treatment of hypertension in the form of a triple ingredient medication has proved to be very successful at bringing hypertensive patients to target levels of 140/90 mm Hg or less.
-
NZ isotretinoin alert
Thursday | Aug 16 2018NEW Zealand's Centre for Adverse Reactions Monitoring is encouraging reporting of cases of Obsessive Compulsive Disorder in connection with isotretinoin for severe acne, after a 14-year-old male developed the condition shortly after starting treatment.
-
Dispensary Corner
Thursday | Aug 16 2018
16 Aug 18TIRED of waiting for attention in the emergency department of your local hospital?.
-
-
Pharmacists too busy for ADRs
Wednesday | Aug 15 2018THE high accessibility of community pharmacists in Australia means they are ideally placed to document adverse drug reactions (ADRs) - but a lack of time, the complexity of the reporting process and insufficient training means under-reporting is "highly prevalent" according to a new University of Tasmania study published last Fri.
-
UK Viagra sales soar
Wednesday | Aug 15 2018A move to make erectile dysfunction medications available over-the-counter in UK pharmacies this year has resulted in "firm growth" in Viagra sales, according to market analyst firm IRI.
-
Attia refused license
Wednesday | Aug 15 2018THE Civil and Administrative Tribunal of New South Wales has refused an application by convicted pharmacist Mina Attia to reinstate his license to practise.
-
SHPA journal out
Wednesday | Aug 15 2018THE Aug edition of the Society of Hospital Pharmacists' Journal of Pharmacy Practice and Research has been published online, with a strong focus on communication and cooperation between pharmacists and other health professionals.
-
FDA Fabry approval
Wednesday | Aug 15 2018THE US Food and Drug Administration has approved Galafold (migalastat), which is the first medication for adults with hereditary disorder Fabry Disease.
-
ASMI Skerritt update
Wednesday | Aug 15 2018THE Australian Self-Medication Industry (ASMI) will host a regulatory update on Fri 31 Aug in North Sydney featuring Adj.
